Fresh Equities
CRESO PHARMA LIMITED

CRESO PHARMA LIMITED

ASX:CPH

Pharmaceuticals

Live Capital Raise

CRESO PHARMA LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10

Capital Raise History


Company Overview

Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

Level 1/1 Altona St, West Perth WA 6005, Australia

Pharmaceuticals
Health Care

Quarterly Cash Flows
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Directors


Announcements, Interviews, News, and Presentations


More Companies Raising Right Now


Other Companies You Might Like

Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Archive

Support

This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.